Cardiology Conferences | Heart Congress | World Cardiology Conferences | Cardiovascular Disease Conferences | CME Conferences | London | UK | Europe | USA | Middle East

Theme: Acquire to make your Heart healthier in the midst of outbreak

World Cardiology-2024

Scientific Program

Renowned Speakers

Guido Lanzillo
Policlinic of Monza
Italy

Esteban Martin Kloosterman
Boca Raton Regional Hospital, Florida Atlantic University
USA

Kevin A. Courville
Prevail Heart Clinics
USA

Ingrid E. Dumitriu
St. Georgeâ€™s University of London
UK

Krasimira Hristova
National Heart Hospital
Bulgaria

Rainer G. H. Moosdorf
University Hospital of Giessen and Marburg GmbH
Germany

Hiroki Kajihara
Hiroshima Prefictural Medical Association
Japan

Marco Diena
Clinica San Gaudenzio
Italy

Marco PicichÃ¨
San Bortolo Hospital
Italy

Sergey Suchkov
Sechenov University, Moscow Engineering Physical University (MEPhI)
Russia

World Cardiology-2024

39^th World Cardiology Conference [World Cardiology 2024] is an international conference, which is going to held during JANUARY 25-26 | 2024 at LONDON | UK. World Cardiology 2024 will be an investigation of new research Innovation in the field of Cardiology and spread the most recent advancements in heart disease prevention and rehabilitation which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops, Speaker sessions. Argument on new technology enhancement in the field of Cardiovascular Disease and current practices in cardiovascular therapy, Cardiac progenitor cells, Hypertension for the primary care clinician, Stent procedure, Balloon Valvuloplasty, Coronary thrombectomy, Non-invasive cardiac imaging, Heart failure, Congestive heart failure, Sports Cardiology and more. Differentiating heart disease and other cardiac conditions constitute a team of healthcare professionals, of which the Cardiology technologist is a key player.

Conference Name

Conference Name	Place	Date
39^_th World Cardiology Conference	LONDON \| UK	JANUARY 25-26 \|2024

Theme: Acquire to make your Heart healthier in the midst of outbreak

Conference Series LLC Ltd. Organizes 3000+ conferences, 1000+workshops and 1000+symposiums on Clinical, Medicine, Nursing, cardiology diagnosis workshops, cardiac nursing conferences, Cardiology Conferences, Heart conferences and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 700 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

We aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical professionals like Directors, Heads, Deans, Professors, Scientists, Researchers, Cardiologists, Founders and Employees of the related companies, Associations, Organizations, Laboratory members and Young researchers working in the field of Cardiology & Heart treatment. This Cardiology Conference mainly focuses on spreading the awareness about challenges in this fields and how to prevent and manage the techniques of Cardiac Imaging, Cardiology and Cardiac nursing.

WHY TO ATTEND?

Encounter the target market with members from across the globe, committed to learn about Cardiology techniques. This is the best opportunity to outreach the largest gathering of participants from around the world. This Cardiology conference in the year 2024 at LONDON | UK will coordinate, disperse

Track 01: Cardiovascular Diseases

Cardiovascular disease involves the improper functioning of heart or blood vessels. Cardiovascular disease includes coronary artery diseases such as angina and myocardial infarction (which is also known as a heart attack). Other cardiovascular diseases are stroke, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, atrial fibrillation, congenital heart disease, endocarditis, peripheral artery disease and venous thrombosis. It is expected that 90% of cardiovascular disease is avoidable. Prevention of atherosclerosis is by decreasing risk factors through: proper diet, exercise, avoidance of tobacco smoke and restrictive alcohol intake. Treating high blood pressure and diabetes is also beneficial. Treating people who have strep throat with antibiotics can reduce the risk of rheumatic heart disease. Cardiovascular diseases are the leading cause of death globally.

Track 02: Cardiac Electrophysiology

Cardiac electrophysiology is the science deals with elucidating, diagnosing, and treating the electrical activities of the heart. The term is used to describe studies of such phenomena by invasive (intracardiac) catheter recording of spontaneous activity as well as of cardiac responses to programmed electrical stimulation (PES). These studies are performed to assess complex arrhythmias, elucidate symptoms, evaluate abnormal electrocardiograms, assess risk of developing arrhythmias in the future, and design treatment. These procedures mainly include therapeutic methods (typically radiofrequency ablation, or cryoablation) in addition to diagnostic and prognostic procedures. Other therapeutic modalities employed in this field include antiarrhythmic drug therapy and implantation of pacemakers and automatic implantable cardioverter-defibrillators (AICD).

Track 03: Clinical Cardiology

A clinical cardiologist analyses and treats the disorder that affects the cardiovascular system, which includes the heart and the blood vessels. Cardiology congresses 2018 employees medications and other non-surgical procedures to cure and prevent the heart attacks, coronary artery diseases and other similar conditions. Cardiology 2018 includes Cardiovascular Medicine, Percutaneous Coronary Intervention and Application of Cardiac Progenitor Cells and many more to be discussed in international congress of cardiology. Many of the universities are working on Clinical Cardiology.

Track 04: Vascular Heart Diseases

Vascular heart diseases are any disease process involving one or more of the four valves of the heart (the aortic and mitral valves on the left and the pulmonary and tricuspid valves on the right). These conditions occur mostly as a result of aging. Most people are in their late 50s when diagnosed, and more than one in ten people over 75 have it.

Track 05: Interventional Cardiology

Interventional cardiology deals especially with the catheter based treatment of structural heart diseases. Andreas Gruentzig is considered the father of interventional cardiology after the enlargement of angioplasty by interventional radiologist Charles Dotter.

A large number of procedures can be accomplished on the heart by catheterization. This is most commonly method which is involves the insertion of a sheath into the femoral artery (but, in practice, any large peripheral artery or vein) and cannulating the heart under X-ray visualization. The radial artery also be used for cannulation; this approach deals with several advantages, including the accessibility of the artery in most patients, the easy control of bleeding even in anticoagulated patients, the enrichment of comfort because patients are capable of sitting up and walking immediately following the procedure, and the near absence of clinically significant sequelae in patients with a normal Allen test.

Track 06: Echocardiography

Echocardiography is a painless test that uses sound waves to create moving pictures of your heart. The pictures show the size and shape of your heart. They also show how well your heart's chambers and valves are working. Echo also can pinpoint areas of heart muscle that aren't contracting and working because of poor blood flow or injury from a previous heart attack. A type of echo called Doppler ultrasound shows how well blood flows through your heart's chambers and valves.

Echo can detect possible blood clots inside the heart, fluid build-up in the pericardium, and problems with the aorta. The aorta is the main artery that carries oxygen-rich blood from your heart to your body. Doctors also use echo to detect heart problems in infants and children.

Track 07: Cardiovascular Surgeries

Cardiac surgery is generally performed on heart or great vessels . Frequently, it is done to treat The complications of ischemic heart disease, correct congenital heart disease, or treat Valvular heart disease from various causes including endocarditis, rheumatic heart disease and atherosclerosis are generally treated by this method.. The procedures implemented in cardiac surgery are: Aortic Aneurysms & Dissections, Coronary Artery Bypass Grafting, Left Ventricular Assist Device and Heart Transplantation, Mitral Valve Surgery and Open-Heart Surgery etc.

Track 08: Pediatrics Cardiology

Paediatric Cardiology is used for the diagnosis of congenital heart defects, performing diagnostic processes such as echocardiograms, cardiac catheterizations and electrophysiology studies. The growing number of neonates with congenital heart defects raised to the neonatal intensive care unit reflects the increasing awareness that the defects may be present. Chest radiography and ECG hardly support in the neonatal analysis. Congestive heart failure in the foetus, or hydrops, can be detected by performing fetal echocardiography. Many of the paediatric heart defects such as patent ducts arteriosus interruption, pericardial window, diaphragm placation, thoracic duct ligation, ligation of collateral vessels have been repaired using paediatric interventional cardiology. The nursing and care techniques also used for paediatric cardiac patients also plays an important role for the treatment of paediatric cardiac patients.

Track 09: Cardiovascular Diabetology, Obesity & Stroke

Obesity raises the risk for heart disease and stroke. But it harms more than just the heart and blood vessel system. It is also a major reason of gallstones, osteoarthritis and respiratory problems. Obesity is closely intertwined with numerous health conditions that underlie cardiovascular disease with high blood pressure, diabetes, and irregular blood cholesterol. In addition, weight increase is a frequent result of heart-damaging lifestyle choices such as deficiency of exercise and a fat-laden diet. Obesity also can lead to heart failure. This is a serious situation in which your heart can't pump enough blood to encounter your body's needs. Having diabetes or pre diabetes puts one at increased risk for heart disease and stroke. One can decreased its risk by possession the blood glucose (also called blood sugar), blood pressure, and blood cholesterol close to the recommended target numbers—the levels suggested by diabetes experts for good health. Stroke and coronary heart disease can be caused by the same problem – atherosclerosis

Track 10: Device Therapy

People who have severe heart failure and irregular heartbeats are candidates for implantable defibrillators. These procedures are surgically placed and deliver pacing, or an electric counter shock, to the heart when a life-threatening abnormal rhythm is detected. People by heart failure develop irregular conduction of the heart’s electrical system that changes how efficiently the heart beats. Cardiac resynchronization therapy (CRT), which is also known as biventricular pacing, may be needed. The left ventricle is the large, muscular chamber of the heart that pumps blood out to the body. A left ventricular assist device is a battery-operated, mechanical pump-type device that's surgically implanted. Heart failure can develop when blockages in the coronary arteries restrict the blood supply to the heart muscle. Removal of these blockages can improve overall heart function, which may recover or resolve heart failure symptoms. Percutaneous coronary intervention is one type of procedure to reopen blocked vessels. Coronary artery bypass surgery reroutes the blood supply around a blocked section of the artery. During this procedure, surgeons remove strong blood vessels from another part of the body, such as a leg or the chest wall. They then surgically attach the vessels to the diseased artery in such a way that the blood can flow around the blocked section.

Track 11: Cardiology Case Reports

Cardiology is a branch of medical science that deals with disorders of the heart. Heart is an important muscular organ in humans and animals that pumps blood through the blood vessels of the circulatory system. The drugs used to treat other disorders in body show a great impact on heart causing various side effects. Hence case reports on cardiac disorders and diseases have a great value that help in advancing and development of various treatment strategies. World Cardiology 2018 will help in networking, partnering between professionals and academicians to share new ideas and advancements in reducing heart failure and heart diseases. The event is designed to build good relations bringing the researchers and companies together. Cardiology conferences, cardiology events, cardiologist meetings are very important for the common people to be aware new innovations and advancements in the field of cardiology.

Track 12: Current Research in Cardiology

Cardiology conferences comprises the current research in cardiology contains the new innovative methods that are coming in cardiology related field. In this sub topic we have Statin therapy, Thrombolytic therapy and Cardiac rehabilitation. There are so many associations and societies and the main association for Interventional cardiology is located in USA. Many universities are working on Current Research in Cardiology. Hospitals and Companies around USA are associated with Cardiology. Some research topics in cardiology includes; Electrophysiology and Arrhythmia Research, Myocardial and Heart Failure Research, The Vital Basis of Excitability in the Heart, Genomic Basis for Inherited Cardiovascular Disease, Proteomic Analysis of Heart Disease, Mechanisms of Cardiac Hypertrophy and Remodelling etc.

Track 13: Heart Regeneration

Cardiac regeneration is a broad effort that objectives to repair irretrievably injured heart tissue with cutting-edge science, including stem cell and cell-free therapy. Reparative tools have been engineered to renovate damaged heart tissue and function by the body's natural ability to regenerate. Working together, patients and providers are finding regenerative solutions that restore, renew and recycle patients' own reparative capacity.

Track 14: Nuclear Cardiology

Nuclear cardiology studies the use of non-invasive techniques to assess myocardial blood flow, evaluate the pumping function of the heart as well as visualize the size and location of a heart attack. Among the techniques of nuclear cardiology, myocardial perfusion imaging is the most widely used for the detection and management of coronary artery disease, viability studies to assess for the extent of myocardial infarction and radionuclide cineangiograms to evaluate heart function.

Track 15: Geriatric Cardiology

Geriatric cardiology or Cardio geriatrics is the branch of cardiology that deals with the cardiovascular disorders in elderly people. The field of geriatric cardiology reflects the evolving medical approaches tailored to address the needs of the growing population of oldest old with cardiovascular diseases (CVD). Cardiac disorders such as coronary heart disease (including myocardial infarction, cardiomyopathy, heart failure, arrhythmias (as atrial fibrillation) and others are common and are a major cause of mortality in elderly people. Vascular disorders such as atherosclerosis and peripheral arterial disease cause significant morbidity and mortality in aged people.

Track 16: Hypertension

Hypertension is another name for high blood pressure. It’s a disease that can lead to severe complications and increases the risk of heart disease, stroke, and death. Blood pressure can be defined as the force exerted by the blood against the walls of the blood vessels and the pressure depends on the work being done by the heart and the resistance of the blood vessels. Medical guidelines define hypertension as a blood pressure higher than 130 over 80 millimetres of mercury (mmHg), according to guidelines issued by the American Heart Association (AHA) in November 2017. Around 85 million people in the United States are suffering from high blood pressure. Hypertension and heart disease are the leading global health concerns. The World Health Organization (WHO) suggests that the growth of the processed food industry has impacted the amount of salt in diets worldwide, and that plays a role in hypertension.

Track 17: Cardiomyopathy & Heart Failure

Heart failure commonly known as chronic heart failure (CHF) occurs due to the inability of the heart to pump blood properly in order to meet the body requirements. Common causes of heart failure include coronary artery disease, high blood pressure, atrial fibrillation, Valvular heart disease, excess consumption of alcohol, infection, and cardiomyopathy of an unknown cause. Heart failure is of two types: heart failure due to left ventricular dysfunction and heart failure with normal ejection fraction. All the cardiology events this year will help in networking, B2B partnering between professionals and academicians working in the field of cardiology. We have handled many successful cardiology events and cardiology conferences and help to build good relations bringing the researchers and companies together. Cardiology conferences, cardiologist meetings and cardiology events are very important for the common people to be aware of the most important part of human body.

Track 18: Cardiac Nursing

Cardiac nursing is a nursing specialty that deals with the patients who are suffering from various conditions of the cardiovascular system. Cardiac nurses help to treat conditions such as unstable angina, congestive heart failure, coronary artery disease, cardiomyopathy, myocardial infarction and cardiac dysrhythmia under the guidance of a cardiologist. Cardiac nurses perform postoperative care on a surgical unit, cardiac monitoring, stress test evaluations, vascular monitoring, and health assessments. Cardiac nurses work in many different environments, including coronary care units (CCU), cardiac catheterization, operating theatres, intensive care units (ICU), cardiac rehabilitation centers, cardiac surgery wards, clinical research, cardiovascular intensive care units (CVICU), and cardiac medical wards.

Track 19: Women Heart Health

Men and women are very different when it comes to matters of the heart, and that’s just as true for matters of heart health. While heart disease is on the decline among men, it is continuously rising among women. It’s the number one killer of women over 35 worldwide, accounting for more deaths every year than all cancers combined. Women with diabetes generally have higher CVD mortality rates than men with diabetes. Women engaged in physical activity for less than an hour per week have 1.48 times the risk of developing coronary heart disease, comparing to the women who do more than three hours of physical activity per week. Go Red for Women is a major international awareness campaign that is dedicated to the prevention, diagnosis and control of heart disease and stroke in women.

Track 20: Cardiovascular Agents

Cardiovascular agents are cardiac medicines that are used to treat medical conditions associated with the heart or the circulatory system (blood vessels), such as coronary artery disease, arrhythmias, high or low blood pressure, blood clots, high cholesterol, heart failure and stroke. There are many different classes of drugs that come under the general term cardiovascular agent. Some work directly on the blood vessels surrounding the heart, reducing how much force the heart has to pump against the wall. Others lower cholesterol levels and help reduce the formation of atherosclerotic plaques which cause narrowing of blood vessels. Some work for the kidneys to increase fluid and salt loss or improve blood flow through the kidneys. The type of cardiovascular disease the person has determines which class of cardiovascular agent to use.

Track 21: Congenital Heart Diseases

Congenital heart disease is one or more abnormalities in the heart's structure at birth. It mostly affects the walls, valves, or blood vessels of the heart. There are different types of congenital heart defects, some are serious and may need several surgeries and treatments.

Track 22: Cardiovascular Diseases during Pregnancy

The evaluation of individuals with valvular heart disease who are or wish to become pregnant is a problematic issue. Issues that have to be addressed include the risks in pregnancy to the mother and the increasing foetus by the presence of maternal valvular heart disease as an intercurrent disease in pregnancy. Common physiological variations during pregnancy require, on average, a 50% growth in circulating blood volume that is supplemented by an increase in cardiac output that usually peaks between the mid portion of the second and third trimesters The enlarged cardiac output is due to an increase in the stroke size, and a minor increase in heart rate, averaging 10 to 20 beats per minute. Additionally uterine circulation and endogenous hormones cause systemic vascular resistance to reduction and a disproportionately lowering of diastolic blood pressure causes a catholic pulse pressure. Inferior vena canal obstruction from a gravid uterus in the prone position can result in an abrupt decrease in cardiac preload, which leads to hypotension with weakness and light headedness. During lab or and delivery cardiac output rises more in part due to the related anxiety and pain, as well as due to uterine reductions which will cause an increase in systolic and diastolic blood pressure.

Track 23: Cardiothoracic Surgeries

Cardiothoracic surgery involves the surgical treatment of organs inside the thorax- generally the heart and lungs. The Cardiothoracic surgeons or Cardiac surgeons are the ones who are specialized in cardiology from general surgery. Cardiac procedures are lengthy and carry a definite risk of death. In order to carry a successful surgery it requires support from advanced forms of technology developments and intensive therapy.

Track 24: Cardiovascular Risk Factors

There are many cardiovascular risk factors associated with coronary heart disease and stroke. Some risk factors like family history cannot be modified, but other risk factors such as high blood pressure, can be modified with treatment. Once can necessarily develop cardiovascular disease if he/she have a risk factor. More the risk factors greater the likelihood to have the heart disease, unless one takes action to modify the risk factors and works to prevent them compromising the heart health.

USA:

American Cardiology Association
American College of Cardiology
Association of Cardiologists
American Heart Association- AHA
American Society of Hypertension
Brazilian Society of Cardiology
Heart & Stroke Foundation of Barbados
Argentina Heart Foundation
Argentina Society of Cardiology
Argentina Federation of Cardiology
Canadian Cardiovascular society
The American Society for Preventive Cardiology
American Society of Nuclear Cardiology
American Stroke Association
Society for Cardiovascular Angiography and Interventions
Arizona Society of Echocardiography
Heart Failure Society of America
Canadian Association of Cardiovascular Prevention and Rehabilitation
Elsevier Society Partners in Cardiology
American Society for Preventive Cardiology
American Society of Echocardiography
American Society of Hypertension
Brazilian Society of Hypertension
Canadian Association of Interventional Cardiology
The American Association of Cardiovascular and Pulmonary Rehabilitation
The Society for Cardiovascular Angiography and Interventions Foundation
American Association for Thoracic Surgery
Congenital Cardiac Anaesthesia Society
Northwest Association of Cardiovascular and Pulmonary Rehabilitation
The Society for Cardiovascular Angiography and Interventions Foundation
Vascular and Endovascular Surgery Society
Canadian Association of Interventional Cardiology
Latin American Society of Hypertension
Congenital Heart Surgeon's Society
The Society for Cardiovascular Angiography and Interventions
The Society of Invasive Cardiovascular Professionals
The Society of Thoracic Surgeons
International Society for Applied Cardiovascular Biology

Europe:

World Heart Federation
European Society of Cardiology
World Heart Failure Society
Belgian Society of Cardiology
Austrian Society of Cardiology
British Cardiovascular Society
British Association for Cardiovascular Prevention and Rehabilitation
Philippine Heart Association
Swiss Society of Cardiology
Association of European Pediatric and Congenital Cardiology
Belorussian Scientific Society of Cardiologists
British Hypertension Society
Moldavian Society of Cardiology
Association of Cardiologists of Bosnia & Herzegovina
Austrian Heart Foundation
Austrian Society of Cardiology
Hellenic Cardiology Society
Estonian Society of Cardiology
Society for Cardiology Science & Technology
The Finnish Cardiac Society
British Congenital Cardiac Association
Spanish Society of Cardiology
Uruguayan Society of Cardiology
German Cardiac Society
Luxembourg Society of Cardiology
British Junior Cardiologists Association
The Egyptian Society of Cardiology
The Hungarian Society of Cardiology
European Association for Cardio-Thoracic Surgery
Heart Valve Society
Italian Society of Cardiology
Portuguese Society of Cardiology
Kyrgyz Society of Cardiology
Norwegian Society of Cardiology
Slovenian Society of Cardiology
Hellenic Cardiovascular Research Society
Icelandic Heart Association
Netherlands Society of Cardiology
Irish Cardiac Society
European Association of Cardiothoracic Anaesthesiologists
Belorussian Scientific Society of Cardiologists

Asia pacific:

Asian Pacific Society of Hypertension
Asia Pacific Hearth Rhythm Society
Association of Cardiologists of Kazakhstan
National Center of Cardiology and Therapy
Cyprus Society of Cardiology
Algerian Society of Hypertension
Russian Society of Cardiology
Armenian Cardiologists Association
Saudi Heart Association
Turkish Society of Cardiology
Emirates Cardiac Society
Egyptian Cardiology Society
Iranian Heart Association
Asian Pacific Society of Cardiology
Cardiac Society of Australia & New Zealand
The Japanese Heart Failure Society
Japanese Society of Echocardiography
The World Society of Cardiovascular & Thoracic Surgeons
Asian Pacific Society of Hypertension
Association of Cardiologists of Kazakhstan
Australian Cardiovascular Health and Rehabilitation Association
Association of Thoracic and Cardiovascular Surgeons of Asia
Chinese Society of Cardiology
The Pan-African Society of Cardiology
Association of Pediatric Cardiology
Cardiology Society of India
Asian Society of Cardiovascular Imaging
Association of Black Cardiologists
Interventional Cardiovascular Society of Malaysia
Israeli Cardiology and Critical Care Nursing Society
Japanese Society of Thoracic Radiology
Korean Society for Thoracic and Cardiovascular Surgery
Kyrgyz Society of Cardiology
Lebanese Society of Cardiology
The Heart foundation of Malaysia
The Japanese Society of Hypertension

Market Analysis:

Aim of this 39th World Heart Congress is to ensure clinically appropriate cost effective care for your members with heart disease. It arises mainly because of ischemic heart disease, stroke, dyslipidemia, thrombosis, atherosclerosis, coronary artery diseases, peripheral artery disease, hypertension and others. The main cause for this disorder includes unhealthy dietary habits, obesity, smoking, high cholesterol, lack of physical activity, excessive alcohol and poor lifestyle. Cardiovascular Diseases is accountable for approximately 15 million deaths each year across the globe and it also states that it is a major cause of death in adults approx. to 50%. A committed forum for the increasing, execution and exchange of information about Cardiovascular Medicine and its areas can be brought up by National/International symposiums, Organizing Conferences and Workshops.

Aetiology, clinical characteristics and therapy:

The aetiology of Heart Failure was hypertension in 45% of the patients while cardiomyopathies were behind 28%, rheumatic heart disease 12%, Ischemic heart disease 9% and other reasons (probable tuberculosis or HIV-related cardiomyopathies, endomyocardial fibrosis and obstructive lung disease) in 6%. is Among those with cardiomyopathies, Heart Failure due to idiopathic dilated cardiomyopathy was most frequent (81%), followed by postpartum cardiomyopathy (15%) while hypertrophic and restrictive cardiomyopathies were rare (5%). Rheumatic mitral disease with regurgitation was the most prevalent valvular lesion (81%), followed by mitral stenosis (15%) and aortic regurgitation (3%).

Importance and Scope: -

World Cardiology Meeting will be the best platform for all the scientists, cardiologists, oncologists, electro physiologists, surgeons, nurses, research scholars, students who are working in this field to exchange their knowledge related to Cardiology and Cardiac Surgery. This international event is an effort to find an alternative for invasive imaging technique against heart diseases and heart failure conditions in adults & children.

Growth of Cardiology Market: -

North America is the dominant regional market for heart diagnostics with a share of approximately 47% of the overall heart diagnostics market in terms of revenue in 2018, followed by Europe which accounted for around 38% share in the market and then by Asia accounting for 15% share.

Statistics of Physicians, Researchers and Academicians working on Cardiology Research

The main part of the world associated with Cardiology field are Directors, Heads, Deans, Professors, Scientists, Researchers, Doctors, Students and Writers of Pediatric Cardiology Department as well as Founders and Employees of the related companies, Associations members, related organizations, laboratories members etc.

The important goal of heart-failure therapy is to inhibit the progression of congestive heart failure through pharmacological, device-based therapies. Therefore, there have been efforts to develop device-based therapies aimed at improving cardiac reserve and optimizing pump function to meet metabolic requirements. The course of congestive heart failure is often worsened by other conditions, including new-onset arrhythmias, ischemia and infarction, valvulopathy, decompensation, end-organ damage, and therapeutic refractoriness, that have an impact on outcomes. The onset of such conditions is sometimes heralded by subtle pathophysiologic changes, and the timely identification of these changes may promote the use of preventive measures. Consequently, device-based methods could in the future have an important role in the timely identification of the subtle pathophysiologic changes associated with congestive heart failure.

Target Audience:

Cardiologists
Professors, Associate Professors
Heart Societies & Associations
Cardio-thoracic Surgeons
Cardiac Surgeons
Research Scholars
Cardiology Fellows
Research Institutes
Vascular Biologists
Manufacturing
Associations and Societies of Cardiology
Training Institutes
Cardiology Students, Scientists
Cardiology and Cardiac Nursing Associations
Graduates and Post Graduates
Directors, CEO’s of Organizations
Medicine Experts

Related Companies/Industries:

MEDNAX, Inc
AstraZeneca
Sanofi
Boehringer Ingelheim
Roche
Bristol-Myers Squibb
United Therapeutics
Astellas
Actelion
Sanofi
Takeda
Otsuka
Gilead Sciences
Johnson & Johnson

Related Associations and Societies:

European Society of Cardiology
American Association of Heart Failure Nurses (AAHFN)
American Society of Nuclear Cardiology (ASNC)
American Society for Echocardiography
Pediatric Cardiology Associates

Related Universities:

Europe:

University Maastricht/Academic Hospital Maastricht
Medical University of Graz
University of Debrecen Medical School
University of Nicosia Medical School
Imperial College London
Johns Hopkins University
Bukovinian State Medical University
Heidelberg University
Hamburg University
University of Lodz

World Wide:

Vanderbilt University
Cornell University
University of Washington
University of Michigan
Harvard University
University of Texas South-western Medical Centre
University of Alabama-Birmingham
Emory University
Yale University
North-western University
Vanderbilt University
University of Rochester

In the presence of cardiologists, professional researchers, scientists, practitioners and medical students involved in the development of high-quality education in all aspects of clinical skills, Conference Series 38^th World Cardiology 2023 was held during March 27-28, 2023 London,UK.

Conferences Group played host to a diverse panel of key members of the World Cardiology 2023 community from research lab, industry, academia and financial investment practices, discussing the future of Cardiology and Cardiovascular specialties. This event was really aimed for examining where the real cardio-logical specialties are going to the future and purpose of the event was to provide an opportunity for cross-fertilization of ideas and development of ideas, in the field of Cardiology.

Focusing on Cardiology, Paediatric Cardiology, Heart Diseases, Echocardiography, Interventional Cardiology, Heart and Blood Vessel Surgeries, Cardiac Nursing, Diabetes, Cardiac Surgeries, Case Reports on Cardiology and the Heart and Heart Failure as well, the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by Honourable Guests and members of the Keynote forum.

The highlights of the meeting were the eponymous lectures, delivered by:

S. Jamal Mustafa, West Virginia University, USA
Brajesh Mittal, Garhoud Private Hospital,
Nandkishore Kapadia, KDA Hospital and Medical Research Institute, India
Syed Raza, Awali Hospital, Bahrain
Yassmin Hanfi, Dallah Private Hospital, Saudi Arabia
Ahmed Mohammed Samman, Ministry of Health, Saudi Arabia
Olivier Jegaden, Mediclinic Airport Road Hospital, United Arab Emirates
Shyam K Ashok, Aster CMI Hospital, India
Kashif Bin Naeem, Al Baraha Hospital, UAE
Yagoub Musa, Alshaab Teaching Hospital, Sudan

These talks were of great interest to the general cardiologists and were enormously informative.

38^th World Cardiology 2023 was a great success with the support of international, multi-professional steering committee and coordinated by the Journal of Cardiovascular Diseases & Diagnosis; Journal of Clinical & Experimental Cardiology and Cardiovascular Pharmacology: Open Access. We are happy to announce our “39^th World Cardiology 2023” going to be held during January25-26,2023| London,UK.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	January 25-26, 2024
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View